Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine.

Abstract:

:Dexmedetomidine is a novel alpha 2-adrenoceptor agonist that may provide beneficial effects as premedication for anesthesia. The pharmacokinetics and pharmacodynamics of transdermal (TD) and intravenous (i.v.) dexmedetomidine were studied in nine healthy male subjects in a crossover trial. The TD preparation, containing 625 micrograms of dexmedetomidine base, was applied on the forehead and left in place for 12 h. The i.v. dose (2.0 micrograms.kg-1 as dexmedetomidine hydrochloride) was administered as an infusion over 5 min. Dose-normalized total AUC values were used to calculate dexmedetomidine bioavailability. The bioavailability of dexmedetomidine from the TD preparation was 51%. However, the bioavailability of dexmedetomidine released from the preparation was 88%. The mean terminal half-life was 3.1 h after i.v. and 5.6 h after TD administration. After TD administration, the mean maximal reductions in blood pressure (systolic/diastolic) and heart rate were 28/20 mmHg, and 19 beats.min-1. A sedative effect was obvious within 5 min and 1-2 h after i.v. and TD administration, respectively.

journal_name

Eur J Clin Pharmacol

authors

Kivistö KT,Kallio A,Neuvonen PJ

doi

10.1007/BF00194403

subject

Has Abstract

pub_date

1994-01-01 00:00:00

pages

345-9

issue

4

eissn

0031-6970

issn

1432-1041

journal_volume

46

pub_type

临床试验,杂志文章,随机对照试验
  • A collaborative intervention to improve surgical antibiotic prophylaxis in children: results from a prospective multicenter study.

    abstract:PURPOSE:The use of surgical antibiotic prophylaxis (SAP) in children is poorly characterized. Our aim was to evaluate the effectiveness of a quality improvement (QI) intervention targeting SAP in children, by means of a multicenter prospective intervention study, with a before and after design. METHODS:We prospectivel...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s00228-017-2270-y

    authors: Ciofi Degli Atti M,Alegiani SS,Raschetti R,Arace P,Giusti A,Spiazzi R,Raponi M,APACHE Study Group.

    更新日期:2017-09-01 00:00:00

  • Additional mechanisms of nafamostat mesilate-associated hyperkalaemia.

    abstract:OBJECTIVE:Nafamostat mesilate, a potent protease inhibitor, is widely used for the treatment of pancreatitis, disseminated intravascular coagulation and as an anticoagulant in haemodialysis. However, hyperkalaemia associated with nafamostat mesilate has been reported. It is thought to be due to decreased urinary potass...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050176

    authors: Ookawara S,Tabei K,Sakurai T,Sakairi Y,Furuya H,Asano Y

    更新日期:1996-01-01 00:00:00

  • Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.

    abstract:OBJECTIVE:The multidrug resistance gene 1 (MDR1) seems to play a role in the carcinogenesis of colorectal tumors. The importance of MDR1 SNPs 2677G > T/A in exon 21 and 3435C > T in exon 26 for cancer susceptibility, however, has not yet been clearly defined. METHODS:Two hundred and eighty-five colorectal cancer patie...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-006-0225-9

    authors: Osswald E,Johne A,Laschinski G,Arjomand-Nahad F,Malzahn U,Kirchheiner J,Gerloff T,Meisel C,Mrozikiewicz PM,Chernov J,Roots I,Köpke K

    更新日期:2007-01-01 00:00:00

  • Interaction between valproate formulation and phenytoin concentrations.

    abstract::Changes in phenytoin concentrations caused by switching valproate formulations with different absorption rates were retrospectively investigated in eleven epileptic patients receiving treatment with both drugs. Total plasma phenytoin concentrations were measured before and after a standard tablet of valproate was repl...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00202174

    authors: Suzuki Y,Nagai T,Mano T,Arai H,Kodaka R,Matsuoka T,Itagaki Y,Ono J,Okada S

    更新日期:1995-01-01 00:00:00

  • Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.

    abstract:PURPOSE:Tamsulosin is one of the most potent drugs currently available to treat benign prostatic hyperplasia. Cytochrome P450 (CYP) 2D6 and CYP3A are the two major enzymes responsible for tamsulosin metabolism. The purpose of this study was to evaluate the effects of CYP2D6 and CYP3A5 genetic polymorphisms on the pharm...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-018-2501-x

    authors: Kim KA,Park IB,Park JY

    更新日期:2018-10-01 00:00:00

  • Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man.

    abstract::Clonazepam (CNP) and its principal metabolite in plasma, 7-amino-CNP (ACNP), have been investigated in a prospective study of 27 newly diagnosed epileptics and correlated with specified side-effects. At a daily dose of 6 mg, the average plasma levels of both substances were about 50ng/ml, and individual values ranged ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00567123

    authors: Sjö O,Hvidberg EF,Naestoft J,Lund M

    更新日期:1975-04-04 00:00:00

  • Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials.

    abstract:PURPOSE:The objective of this study was to appraise the safety profiles of HES preparations and to find out which HES preparation was the most acceptable in cardiovascular surgery through a comparison with control solutions. METHODS:Pertinent randomized controlled trials were selected through a search of Pubmed, Embas...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s00228-011-1008-5

    authors: Shi XY,Zou Z,He XY,Xu HT,Yuan HB,Liu H

    更新日期:2011-08-01 00:00:00

  • Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs.

    abstract:PURPOSE:The purpose of this study was to investigate the influence of patient characteristics such as age and stroke and bleeding risks on decisions for antithrombotic treatment in patients with atrial fibrillation (AF). METHODS:This was a retrospective, population-based study including AF patients initiated with eith...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-017-2289-0

    authors: Komen J,Forslund T,Hjemdahl P,Wettermark B

    更新日期:2017-10-01 00:00:00

  • An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.

    abstract:BACKGROUND:Maintenance of the structural and functional integrity of the skeleton is a critical function of a continuous remodeling driven by highly associated processes of bone resorption and synthetic activities driven by osteoclasts and osteoblasts, respectively. Acceleration of bone turnover, accompanied with a dis...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-006-0174-3

    authors: Leeming DJ,Alexandersen P,Karsdal MA,Qvist P,Schaller S,Tankó LB

    更新日期:2006-10-01 00:00:00

  • Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients.

    abstract:OBJECTIVES:The aims of the study were to assess the correlation between the plasma concentration of ophthalmic timolol and cardiovascular parameters, and the influence of timolol on advanced haemodynamic variables, such as stroke (SI), cardiac (CI) and systemic vascular resistance (SVRI) indices and arterial pulse wave...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s00228-005-0945-2

    authors: Nieminen T,Uusitalo H,Turjanmaa V,Bjärnhall G,Hedenström H,Mäenpää J,Ropo A,Heikkilä P,Kähönen M

    更新日期:2005-07-01 00:00:00

  • Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis.

    abstract:PURPOSE:In the past few years, several fracture-related events have been reported with chronic use of selective serotonin reuptake inhibitors (SSRIs) throughout the globe. Hence, an updated systematic review and meta-analysis was necessary to ascertain the risk involved. The present work evaluated the association of SS...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-020-02893-1

    authors: Kumar M,Bajpai R,Shaik AR,Srivastava S,Vohora D

    更新日期:2020-10-01 00:00:00

  • Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine.

    abstract::The presence of a possible correlation between changes in left ventricular mass of hypertensive patients and the degree of blood pressure reduction with different antihypertensive drugs has been investigated in 40 outpatients by M-mode echocardiography. Ten of these, with blood pressure in normal limits with different...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00556886

    authors: Ferrara LA,de Simone G,Mancini M,Fasano ML,Pasanisi F,Vallone G

    更新日期:1984-01-01 00:00:00

  • Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.

    abstract:OBJECTIVE:Valsartan (V), a specific inhibitor of the angiotensin II receptor subtype, AT1, has been developed for treatment of hypertension. Combination therapy with a beta-adrenoceptor blocking agent might be considered in cases with insufficient efficacy of V alone. Therefore, an interaction trial was performed to ev...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280050318

    authors: Czendlik CH,Sioufi A,Preiswerk G,Howald H

    更新日期:1997-01-01 00:00:00

  • A drug interaction study between cicletanine and tolbutamide in healthy volunteers.

    abstract:OBJECTIVE:To determine the possible interaction between the antihypertensive agent cicletanine and the hypoglycaemic drug tolbutamide. METHODS:Time-courses of glycaemia and serum immunoreactive insulin (IRI) were followed in 10 healthy subjects after two tolbutamide infusions in each volunteer; initially alone and 9 d...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050127

    authors: Bayés MC,Barbanoj MJ,Vallès J,Torrent J,Obach R,Jané F

    更新日期:1996-01-01 00:00:00

  • Surveillance of suspected adverse reactions to herbal products used as laxatives.

    abstract:AIM:To describe and evaluate spontaneous reports of suspected adverse reactions (ARs) associated with herbal laxatives received by the Italian Medicines Agency and the Italian National Institute of Health between April 2002 and January 2011. METHODS:Spontaneous reports of suspected ARs were individually analyzed by a ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-011-1128-y

    authors: Vitalone A,Menniti-Ippolito F,Raschetti R,Renda F,Tartaglia L,Mazzanti G

    更新日期:2012-03-01 00:00:00

  • Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.

    abstract::The efficacy and safety of almitrine bismesylate, a new respiratory stimulant, in patients with the hypoxaemic form of chronic respiratory insufficiency caused by chronic bronchitis and emphysema has been assessed. The multicentre trial of 12 weeks duration was double-blind and placebo controlled, with individual and ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00315025

    authors: Bakran I,Vrhovac B,Stangl B,Tabori D,Ivicevic A,Todic V,Kandare F

    更新日期:1990-01-01 00:00:00

  • Comparative bioavailability of two different rectal preparations of piroxicam in man.

    abstract::A comparative pharmacokinetic study was performed with two types of suppository each containing 20 mg piroxicam. The bioavailability of piroxicam was studied in 24 healthy volunteers in a double blind, randomised, cross over study. No significant difference was found in the pharmacokinetic parameters [AUC(0-72 h), AUC...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF02333031

    authors: Benkö S,Grézal G,Nagy E,Klebovich I

    更新日期:1992-01-01 00:00:00

  • Transient neutropenia after intravenous injection of vindesine in patients with lung cancer.

    abstract::We have found transient circulating neutropenia and pulmonary sequestration of neutrophils after the intravenous injection of vindesine, a microtubule disruptor. Experiment 1 Ten patients with lung cancer were given a bolus intravenous injection of 3 mg.m-2 vindesine (Fildesine(r)). In all patients, total leukocyte an...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00193474

    authors: Aoshiba K,Nagai A,Ueno H,Konno K

    更新日期:1994-01-01 00:00:00

  • Pharmacokinetics and bioavailability of digitoxin by a specific assay.

    abstract::The pharmacokinetics and bioavailability of digitoxin were examined in six normal human subjects using an assay that separates digitoxin from its metabolites. After intravenous administration, the mean systemic clearance was 2.44 ml/min; the volume of distribution was 0.47 l/kg; and the elimination half-life was 6.5 d...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:

    authors: MacFarland RT,Marcus FI,Fenster PE,Graves PE,Perrier D

    更新日期:1984-01-01 00:00:00

  • Prokinetic effect of AS-4370 on gastric emptying in healthy adults.

    abstract::The effect of AS-4370 on gastric emptying was investigated in healthy adults using 99mTc-DTPA. Single doses of AS-4370 2.5, 5 or 10 mg or placebo were administered to 12 subjects in a controlled, double-blind, cross-over study. Tests were performed twice weekly in each subject. Thirty min after administration of test ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00314963

    authors: Kanaizumi T,Nakano H,Matsui Y,Ishikawa H,Shimizu R,Park S,Kuriya N

    更新日期:1991-01-01 00:00:00

  • Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.

    abstract:PURPOSE:To investigate the impact of valproic acid (VPA) and genetic polymorphism of the major metabolizing enzyme (UGT1A4, UGT2B7) of lamotrigine (LTG) and VPA on LTG concentration in Chinese epileptic children. METHODS:Three single nucleotide polymorphisms (UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2) were analyzed by p...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-015-1925-9

    authors: Liu L,Zhao L,Wang Q,Qiu F,Wu X,Ma Y

    更新日期:2015-11-01 00:00:00

  • Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.

    abstract:BACKGROUND:Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) is a delayed infrequent potentially life-threatening idiosyncratic drug reaction. Aromatic anticonvulsants and allopurinol are the most frequent causative agents. However, various reports of antibiotic-induced DRESS are available. In this...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-020-03005-9

    authors: Sharifzadeh S,Mohammadpour AH,Tavanaee A,Elyasi S

    更新日期:2020-10-06 00:00:00

  • Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes.

    abstract:OBJECTIVE:The aim of this investigation was to clarify the stereoselective properties in lansoprazole metabolism by monitoring the metabolic consumption for each enantiomer and the formation of the main metabolites, lansoprazole sulfone and 5-hydroxylansoprazole, in the presence of human liver microsomal enzymes. METH...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280100374

    authors: Katsuki H,Hamada A,Nakamura C,Arimori K,Nakano M

    更新日期:2001-12-01 00:00:00

  • Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.

    abstract:OBJECTIVE:To quantify the relation between local and systemic magnitudes of effects of inhaled formoterol and salbutamol. METHODS:Twenty-eight stable asthmatic patients completed this double-blind, randomised crossover study. Pre-drug administration FEV1 (mean 2.08 L) was 49-93% of predicted and reversibility 16-82% a...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Rosenborg J,Larsson P,Rott Z,Böcskei C,Poczi M,Juhász G

    更新日期:2002-07-01 00:00:00

  • Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping.

    abstract:PURPOSE:To develop a limited sampling strategy (LSS) to predict area under the concentration-time curve (AUC) ratios of omeprazole (AUC(OPZ)) to its metabolites 5-hydroxyomeprazole (AUC(5OH)) and omeprazole sulfone (AUC(SUL)) as phenotyping parameters for cytochrome P450 (CYP) 2C19 and 3A. METHODS:Data were obtained f...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-011-1136-y

    authors: Lawson EB,Wu JC,Baldwin RM,Ingelman-Sundberg M,Rosenborg S,Yim DS,Yin OQ,Capparelli EV,Ma JD

    更新日期:2012-04-01 00:00:00

  • Correction to: Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data.

    abstract::In the 3rd paragraph and 2nd line of the Conclusion section the correct sentence should be: It is now important to encourage policy and decision makers to facilitate and accommodate future linkage of data. ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,已发布勘误

    doi:10.1007/s00228-017-2358-4

    authors: Sinnott SJ,Bennett K,Cahir C

    更新日期:2017-11-01 00:00:00

  • Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension.

    abstract::Thirty patients with mild or moderate essential hypertension, and a fixed elevation of diastolic blood pressure, were randomly allocated to three groups and treated with propranolol 40 mg x 4 (Group 1), 80 mg x 4 (group 2) and 160 mg x 4 (Group 3). Blood pressure (BP), pulse rate (PR), plasma renin activity (PRA), pla...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00618774

    authors: Pedersen EB,Kornerup HJ,Pedersen OL,Andreasen F,Bjerregaard P

    更新日期:1981-01-01 00:00:00

  • The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin.

    abstract:OBJECTIVE:The effect of age on the pharmacokinetics and pharmacodynamics of prazosin (alpha 1 adrenoceptor blocker) was studied in 20 healthy volunteers. PATIENTS:Ten elderly (61-81 y) and ten young (23-28 y) subjects were studied. All subjects received 1 mg of prazosin orally in a fasting state. Serial blood samples ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s002280050067

    authors: Andros E,Detmar-Hanna D,Suteparuk S,Gal J,Gerber JG

    更新日期:1996-01-01 00:00:00

  • Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man.

    abstract::The effects of an oral dose of atropine (0.03 mg/kg body weight) and an IM (0.02 mg/kg) dose on the heart rate and salivary flow in seven healthy adult volunteers were compared to see whether the oral dose was sufficient to inhibit vagal reflexes of the heart. Atropine concentrations in plasma were determined by an M2...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00192357

    authors: Volz-Zang C,Waldhäuser T,Schulte B,Palm D

    更新日期:1995-01-01 00:00:00

  • Evaluation of a radioreceptor assay for beta-adrenoceptor antagonists in plasma.

    abstract::A radioreceptor assay (RRA) recently developed in this laboratory for beta-adrenoceptor antagonists in plasma was evaluated in normal volunteers and compared with a radioimmunoassay (RIA) for propranolol. The RRA depends upon the ability of beta-adrenoceptor antagonists to complete with a radiolabelled ligand for beta...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00558447

    authors: Barnett DB,Batta M,Davies B,Nahorski SR

    更新日期:1980-05-01 00:00:00